-
Featured Authors
Archive
- March 2014 (1)
- February 2014 (2)
- October 2013 (1)
- September 2013 (1)
- August 2013 (1)
- July 2013 (1)
- June 2013 (2)
- April 2013 (1)
- February 2013 (2)
- January 2013 (1)
- October 2012 (1)
- September 2012 (3)
- August 2012 (1)
- January 2012 (3)
- December 2011 (2)
- October 2011 (3)
- August 2011 (3)
- July 2011 (2)
- June 2011 (12)
- April 2011 (2)
- January 2010 (1)
- November 2009 (1)
- October 2009 (47)
- September 2009 (37)
- August 2009 (1)
- June 2008 (3)
- May 2008 (2)
- April 2008 (1)
- February 2008 (6)
Category Archives: Business of Biotech
Could 3 minutes reshape California’s biotech future?
Ron Leuty from BiotechSF writes: In just three minutes the other day, Maryland received more than 180 applications for its $8 million biotech tax credit program. The program, which rewards investors for putting cash in biotech startups, is one of many that states are offering to jumpstart or grow their life sciences communities.
Evolution of Biotech Industry is a Constant
Healthcare being delivered by smartphone, homes containing treatment capabilities now only found in hospitals, groundbreaking innovations rising from the confluence of technology and science. Change is constant in the biotech industry and few industry experts know its evolution better than Steven Burrill. Burrill, CEO of Burrill and Company, presented his 25th anniversary annual report on the state of the biotech industry Biotech 2011-Life Sciences: Looking Back to See Ahead at the 2011 BIO International Convention Read More >
Biotech Business: Wait Our Model Isn’t Dead
Life sciences company and investment executives debated the current and future viability of the industry model for startup companies, given the tumultuous economic waters it traversed during the so-called Great Recession of 2008-2009. The aptly-named panel (“Wait, Our Model Isn’t Dead! We Just Need to Evolve”) appraised those lean times for biotech in a justifiable effort to explain the dramatic decline of startup generation and flow of available investment funding since the peak of the Read More >
Bioenergy Business Outlook Survey Shows Bullish Market Expectations
Encouraged by the continued demand for alternative fuels, bioenergy executives are optimistic that their industry will be an increasingly investment-driven enterprise, according to the findings of the Summer 2011 Bioenergy Business Outlook survey. The quarterly survey, co-sponsored by Biofuels Digest and BIO, was discussed at the BIO International Convention today by Jim Lane, editor of Biofuels Digest; Brent Erickson, Executive Vice President, BIO; and Adam Monroe, President, Novozymes North America. The survey reflects expectations for Read More >
Author of Building Biotechnology Onsite at the 2011 BIO International Convention
Yali Friedman, author of Building Biotechnology as well as other books is signing books at the BIO bookstore from 3pm to 4:30pm at the 2011 BIO International Convention.
